Our Guides For GHK-CU (Copper Peptide)?
We aim to simplify peptide research by offering:
- Straightforward instructions
- Clear reconstitution steps
- Regular updates
All protocols reference peer-reviewed data where possible and follow research standards.
Snap-8 Dosing & Reconstitution Guide
Educational guide for reconstitution and dosing protocol
Standard / Gradual Approach (Reconstituted with 3 mL = 4 mg/mL)
| PHASE | DAILY DOSE | APPROX. UNITS (PER INJECTION) |
|---|---|---|
| Weeks 1-4 | 400 mcg (0.4 mg) | 10 units |
| Weeks 5-8 | 800 mcg (0.8 mg) | 20 units |
| Weeks 9-12 | 1,200 mcg (1.2 mg) | 30 units |
Reconstitute the vial with 3 mL of bacteriostatic water to create a 4 mg/mL solution. If the calculated injection volume falls below 10 units, consider using a smaller insulin syringe for improved dosing accuracy.
- Draw 3.0 mL of bacteriostatic water into a sterile syringe.
- Inject the water slowly along the vial wall to minimize foam formation.
- Gently swirl the vial until the powder is completely dissolved (avoid vigorous shaking).
- Store the reconstituted solution at 2-8°C (refrigerator), protected from light.
Note: This guide is for research purposes only. Always consult with a qualified professional before use.
Protocol Overview
Enter your block description here. This text will appear below the title and above the bullet points.
- Goal: Investigate metabolic support, fat oxidation, and regenerative properties
- Schedule: Daily subcutaneous injections over a 12-week cycle
- Dose Range: Start at 400 mcg daily, increasing to 1.2 mg daily
- Reconstitution: Reconstitute with 3 mL to achieve a 4 mg/mL solution
- Storage: Freeze lyophilized vials; refrigerate reconstituted solution at 2-8°C
Protocol Overview
The AOD-9604 6mg + CJC-1295 3mg + Ipamorelin 3mg (12mg Blend Vial) protocol combines a lipolytic peptide fragment with two growth hormone secretagogues to potentially enhance metabolic regulation and tissue repair. This research-focused regimen uses daily subcutaneous injections with gradual dose escalation over a 12-week cycle.
- Goal: Investigate metabolic support, fat oxidation, and regenerative properties
- Schedule: Daily subcutaneous injections over a 12-week cycle
- Dose Range: Start at 400 mcg daily, increasing to 1.2 mg daily
- Reconstitution: Reconstitute with 3 mL to achieve a 4 mg/mL solution
- Storage: Freeze lyophilized vials; refrigerate reconstituted solution at 2-8°C
Dosing Protocol
This protocol involves a single daily injection with gradual titration:
- Daily Dose: Begin with 400 mcg (10 units) and increase to 1,200 mcg (30 units) as tolerated
- Injection Frequency: Once daily, preferably at the same time each day
- Cycle Length: 12 weeks (adjustable based on research parameters)
- Note: Ensure consistent dosing intervals and accurate measurement using a 100-unit insulin syringe